Literature DB >> 27156748

Effect of acupuncture on house dust mite specific IgE, substance P, and symptoms in persistent allergic rhinitis.

John Leslie McDonald1, Peter K Smith2, Caroline A Smith3, Charlie Changli Xue4, Brenda Golianu5, Allan W Cripps2.   

Abstract

BACKGROUND: Clinical evidence suggests that acupuncture improves symptoms in persistent allergic rhinitis, but the physiologic basis of these improvements is not well understood.
OBJECTIVE: A randomized, sham-controlled trial of acupuncture for persistent allergic rhinitis in adults investigated possible modulation of mucosal immune responses.
METHODS: A total of 151 individuals were randomized into real and sham acupuncture groups (who received twice-weekly treatments for 8 weeks) and a no acupuncture group. Various cytokines, neurotrophins, proinflammatory neuropeptides, and immunoglobulins were measured in saliva or plasma from baseline to 4-week follow-up.
RESULTS: Statistically significant reduction in allergen specific IgE for house dust mite was seen only in the real acupuncture group, from 18.87 kU/L (95% CI, 10.16-27.58 kU/L) to 17.82 kU/L (95% CI, 9.81-25.83 kU/L) (P = .04). A mean (SE) statistically significant down-regulation was also seen in proinflammatory neuropeptide substance P (SP) 18 to 24 hours after the first treatment from 408.74 (299.12) pg/mL to 90.77 (22.54) pg/mL (P = .04). No significant changes were seen in the other neuropeptides, neurotrophins, or cytokines tested. Nasal obstruction, nasal itch, sneezing, runny nose, eye itch, and unrefreshed sleep improved significantly in the real acupuncture group (postnasal drip and sinus pain did not) and continued to improve up to 4-week follow-up.
CONCLUSION: Acupuncture modulated mucosal immune response in the upper airway in adults with persistent allergic rhinitis. This modulation appears to be associated with down-regulation of allergen specific IgE for house dust mite, which this study is the first to report. Improvements in nasal itch, eye itch, and sneezing after acupuncture are suggestive of down-regulation of transient receptor potential vanilloid 1. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry Identifier: ACTRN 12610001052022.
Copyright © 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27156748     DOI: 10.1016/j.anai.2016.04.002

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  8 in total

1.  Feishu Acupuncture Inhibits Acetylcholine Synthesis and Restores Muscarinic Acetylcholine Receptor M2 Expression in the Lung When Treating Allergic Asthma.

Authors:  Yu-Li Liu; Li-de Zhang; Tie-Ming Ma; Si-Tong Song; Hai-Tao Liu; Xu Wang; Ning Li; Chang Yang; Song Yu
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

2.  Meditative Movement, Energetic, and Physical Analyses of Three Qigong Exercises: Unification of Eastern and Western Mechanistic Exercise Theory.

Authors:  Penelope Klein; George Picard; Joseph Baumgarden; Roger Schneider
Journal:  Medicines (Basel)       Date:  2017-09-23

3.  Is acupuncture dose dependent? Ramifications of acupuncture treatment dose within clinical practice and trials.

Authors:  Matthew Bauer; John Leslie McDonald; Natalie Saunders
Journal:  Integr Med Res       Date:  2020-01-20

4.  Exploring the Mechanism of Yiqi Qingre Ziyin Method in Regulating Neuropeptide Expression for the Treatment of Atrophic Rhinitis.

Authors:  Lixing Lu; Xueran Kang; Bin Yi; Chenyan Jiang; Xiaojun Yan; Bin Chen; Yuxing Sun; Fangze Shi; Yuanbo Luo; Yisheng Chen; Runjie Shi
Journal:  Dis Markers       Date:  2022-03-08       Impact factor: 3.434

5.  Acupuncture for allergic rhinitis: a systematic review and meta-analysis.

Authors:  Min He; Weishan Qin; Zongshi Qin; Changqing Zhao
Journal:  Eur J Med Res       Date:  2022-04-25       Impact factor: 4.981

6.  Effect of acupuncture at the sphenopalatine ganglion for the treatment of moderate to severe seasonal allergic rhinitis: Study protocol for a three-armed randomized controlled trial.

Authors:  Weiming Wang; Hui Chen; Ning Gao; Shudan Yu; Jiahua Liao; Shijie Wang; Ziqi Gao; Zhishun Liu
Journal:  Front Med (Lausanne)       Date:  2022-09-06

7.  Socheongryong-tang for improving nasal symptoms associated with allergic rhinitis: A study protocol for a randomized, open-label, cetirizine controlled, clinical trial.

Authors:  Young-Eun Kim; Mi Ju Son; So Young Jung; Ojin Kwon; Jun-Hwan Lee; Dong-Hyo Lee
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

8.  Acupuncture as an add-on therapy to sublingual allergen-specific immunotherapy for patients with allergic rhinitis.

Authors:  Jiang-Hua Li; Lin-Hong Yang; Ying Chen; Zong-Xian Fan
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.